Thus, we investigated whether the ATP-enhanced inflammasome components are involved in IL-1β secretion and consequently related to tumor progression, including invasion and angiogenesis, in both breast cancer cells, and whether the effects are P2Y2R-dependent. The gene discussed is IL1B; the disease is breast carcinoma.